Treatment of ischemic stroke with erythropoietin enhances neurogenesis in SCID mice

WEN Zhongmin,BAO Shiyao
DOI: https://doi.org/10.3969/j.issn.0253-3685.2006.07.021
2006-01-01
Abstract:Objective To investigate the role of erythropoietin(EPO) in neurogenesis and cortex expansion after permanent cerebral ischemic stroke.Methods Animal model was induced in SCID mice.Left middle cerebral arteries of SCID mice were occluded and cut by a bipolar electrocoagulator at the site 1-2mm lateral middle cerebral artery from left olfactory tract under microscopy.EPO(in group T) or the same volume of BPS(in group C) was administrated intraperitoneally daily for 7days staring at 24 hours after stroke.For labeling proliferation cells,bromodeoxyuidine(BrdU) was injected intraperitoneally daily for 10 days into mice staring at 24 hours after stroke.All mice were euthanized on the 35th day after stroke for the evaluation of neurogenesis and cortical expansion.Results Compared with group C,EPO significantly increased the numbers of anti-BrdU and anti-neuronal nuclei (NeuN) double positive cells at the edge of infarct (3.5±1.5)HP and (16.8±4.3)HP, respectively (P<0.05) and induced the cortical expansion after stroke the cortex width indexes were (0.876±0.009) and (0.935±0.017), respectively(P<0.05).Conclusion Our data suggest that administration of EPO provided therapeutic benefit after stroke involved in neurogenesis and cerebral cortex expanding.
What problem does this paper attempt to address?